retatrutide fda approval status october 2025 💉𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀 𝗨𝗻𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁: 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂 𝗦𝗵𝗼𝘂𝗹𝗱 𝗞𝗻𝗼𝘄 𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲: a new triple-agonist weight loss drug that is STILL IN CLINICAL TRIALS, is showing incredible results, with some Demand for Unapproved Weight-Loss Drug

The heart rate increase from retatrutide is modest and dose-dependent

Because retatrutide loses more total weight faster, a person can lose more absolute muscle even at the same percentage which is precisely why the muscle-preservation levers below matter more, not less, on the strongest compound

| Houston Methodist GLP-1 diabetes and weight-loss drug side effects: "Ozempic face" and more | Harvard Health Semaglutide (oral route) - Side effects & dosage | Mayo Clinic 4 Things to Know Before Trying GLP-1s for Weight Loss | Hartford HealthCare | CT Glucagon-Like Peptide-1 Receptor Agonists - StatPearls | NCBI Bookshelf GLP-1 diabetes and weight-loss drug side effects: "Ozempic face" and more | Harvard Health Semaglutide-associated kidney injury | Clinical Kidney Journal | Oxford Academic

For example, a bowl of yogurt and fruit after a morning run

Want to improve blood sugar regulation and overall metabolic health

Although he acknowledges the line of research is still investigational, he says GLP-1s are an exciting class of drugs